CCL2 and steatosis: CD47 deficiency enhances NF-κB activation, elevates IL-1β, TNFα, IL-6, reduces IL-10, increases CCL2 and macrophage infiltration, leading to exacerbated steatosis, inflammation, and fibrosis.